Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1990 1
1992 2
1993 2
1994 3
1995 1
1997 1
1999 3
2001 3
2002 1
2003 3
2004 1
2005 3
2007 2
2008 2
2009 3
2010 3
2011 6
2012 1
2013 1
2014 2
2015 4
2016 5
2017 11
2018 10
2019 9
2020 7
2021 8
2022 19
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells.
Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M, Tirrò E, Di Bella S, Iacono ML, Pantina VD, Porcelli G, Mangiapane LR, Bianca P, Rizzo A, Sciacca E, Pillitteri I, Vella V, Belfiore A, Bongiorno MR, Pistone G, Memeo L, Colarossi L, Giuffrida D, Colarossi C, Vigneri P, Todaro M, Stassi G. Veschi V, et al. Among authors: vella v. Nat Commun. 2023 Mar 11;14(1):1351. doi: 10.1038/s41467-023-36922-1. Nat Commun. 2023. PMID: 36906579 Free PMC article.
Editorial: Resistance to Endocrine Therapies in Cancer.
Ranganathan P, Chakrabarty A, Hiscox S, Limaye AM, Vella V. Ranganathan P, et al. Among authors: vella v. Front Endocrinol (Lausanne). 2020 Apr 9;11:196. doi: 10.3389/fendo.2020.00196. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32328035 Free PMC article. No abstract available.
Insulin Receptor Isoforms in Cancer.
Vella V, Milluzzo A, Scalisi NM, Vigneri P, Sciacca L. Vella V, et al. Int J Mol Sci. 2018 Nov 16;19(11):3615. doi: 10.3390/ijms19113615. Int J Mol Sci. 2018. PMID: 30453495 Free PMC article. Review.
Long-acting insulin analogs and cancer.
Sciacca L, Vella V, Frittitta L, Tumminia A, Manzella L, Squatrito S, Belfiore A, Vigneri R. Sciacca L, et al. Among authors: vella v. Nutr Metab Cardiovasc Dis. 2018 May;28(5):436-443. doi: 10.1016/j.numecd.2018.02.010. Epub 2018 Feb 24. Nutr Metab Cardiovasc Dis. 2018. PMID: 29609864 Review.
Editorial: Early diagnoses and treatments of uncommon breast cancers.
De Francesco EM, Vella V. De Francesco EM, et al. Among authors: vella v. Front Endocrinol (Lausanne). 2022 Oct 18;13:1042226. doi: 10.3389/fendo.2022.1042226. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36329883 Free PMC article. No abstract available.
Diving into the dark kinome: lessons learned from LMTK3.
Vella V, Giamas G, Ditsiou A. Vella V, et al. Cancer Gene Ther. 2022 Aug;29(8-9):1077-1079. doi: 10.1038/s41417-021-00408-3. Epub 2021 Nov 24. Cancer Gene Ther. 2022. PMID: 34819628 No abstract available.
Editorial: A year in review: discussions in cancer endocrinology.
Almeida M, Sharifi-Rad J, Vella V. Almeida M, et al. Among authors: vella v. Front Endocrinol (Lausanne). 2023 Sep 20;14:1289156. doi: 10.3389/fendo.2023.1289156. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37800140 Free PMC article. No abstract available.
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.
Muoio MG, Pellegrino M, Rapicavoli V, Talia M, Scavo G, Sergi V, Vella V, Pettinato S, Galasso MG, Lappano R, Scordamaglia D, Cirillo F, Pulvirenti A, Rigiracciolo DC, Maggiolini M, Belfiore A, De Francesco EM. Muoio MG, et al. Among authors: vella v. Breast Cancer Res. 2023 Jul 17;25(1):84. doi: 10.1186/s13058-023-01686-5. Breast Cancer Res. 2023. PMID: 37461077 Free PMC article.
121 results